Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Ultragenyx Pharmaceutical (RARE) operate in?

Ultragenyx Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Ultragenyx Pharmaceutical Stock (NASDAQ: RARE) stock price, news, charts, stock research, profile.

Open	$57.60
Close	$56.76
Volume / Avg.	348.80K / 762.02K
Day Range	$56.74 - $57.78
52 Wk Range	31.52 - 60.37
Market Cap	$5.23B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	4.5%
Days to Cover	6.26

Recent News

Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs

Henrietta Lacks' family sues Novartis and Viatris for profiting from her HeLa cells without consent. The lawsuit seeks profits and aims to prevent further unauthorized use of the cells.

Vandana Singh

Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst

Ionis Pharmaceuticals releases positive results from Phase 1/2 study of ION582 for Angelman syndrome, showing consistent clinical improvements in communication, cognition, and motor function. Safety profile is favorable. Phase 3 study planned for 2025.

Vandana Singh

Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$57.60
Close	$56.76
Volume / Avg.	348.80K / 762.02K
Day Range	$56.74 - $57.78
52 Wk Range	31.52 - 60.37
Market Cap	$5.23B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	4.5%
Days to Cover	6.26

About Ultragenyx Pharmaceutical Inc.

Sector

Health Care

Industry

Biotechnology

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, dev...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Ultragenyx Pharmaceutical (RARE) stock?

You can purchase shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) through any online brokerage.

View our list of the best stock brokerages

Who are Ultragenyx Pharmaceutical (RARE) competitors?

Other companies in Ultragenyx Pharmaceutical’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Ionis Pharmaceuticals (NASDAQ:IONS) and Roivant Sciences (NASDAQ:ROIV).

What is the forecast, or price target, for Ultragenyx Pharmaceutical (RARE) stock?

Ultragenyx Pharmaceutical has a consensus price target of $91.72.

What is the current price for Ultragenyx Pharmaceutical (RARE)?

The stock price for Ultragenyx Pharmaceutical (NASDAQ: RARE) is $56.76 last updated September 25, 2024 at 4:00 PM EDT.

Does Ultragenyx Pharmaceutical (RARE) pay a dividend?

There are no upcoming dividends for Ultragenyx Pharmaceutical.

When is Ultragenyx Pharmaceutical (NASDAQ:RARE) reporting earnings?

Ultragenyx Pharmaceutical’s Q3 earnings are confirmed for Thursday, October 31, 2024.

Is Ultragenyx Pharmaceutical (RARE) going to split?

There is no upcoming split for Ultragenyx Pharmaceutical.

What sector and industry does Ultragenyx Pharmaceutical (RARE) operate in?

Ultragenyx Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge